NEW YORK ( TheStreet) -- Luminex Corporation (Nasdaq: LMNX) is trading at unusually high volume Tuesday with one million shares changing hands. It is currently at 4.4 times its average daily volume and trading up 72 cents (+3.2%) at $23.40 as of 3:55 p.m. ET. Luminex has a market cap of $953.5 million and is part of the health care sector and health services industry. Shares are up 2.3% year to date as of the close of trading on Monday. Luminex Corporation engages in the development, manufacture, and sale of proprietary biological testing technologies and products for the life sciences and diagnostic industries. The company has a P/E ratio of 73.8, above the average health services industry P/E ratio of 71.5 and above the S&P 500 P/E ratio of 17.7. TheStreet Ratings rates Luminex as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures, expanding profit margins, solid stock price performance and notable return on equity. We feel these strengths outweigh the fact that the company has had sub par growth in net income. You can view the full Luminex Ratings Report. See all heavy volume stocks in our stocks moving on unusual volume list or get investment ideas from our investment research center.
TheStreet’s Fundamentals of Investing Course will teach you the keys to making the right decisions in any market.
TheStreet’s Personal Finance Essentials Course will teach you money management basics and investing strategies to help you avoid major financial pitfalls.
TheStreet Courses offers dedicated classes designed to improve your investing skills, stock market knowledge and money management capabilities.
More from Markets
'Wear You Out' Action Suggests More Downside to Come
The bears didn't' run scared Monday.
Chart of the Day: Sizing Up the Huawei Hit to Semiconductor Stocks
Not all semiconductor stocks are poised to experience the same headwind from Huawei.
Here's Why I'm Drawn Toward Specialty Retail Stocks Like Lowe's
Although not completely immune to tariffs and Trade Wars, I could see LOW...escaping relatively unscathed.
Home Depot Could Weaken Further in the Weeks Ahead - Watch the 200-Day Line
HD will report quarterly earnings Tuesday before the opening bell.